Nov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overNov. 20 2024
Source Page: Elafibranor for previously treated primary biliary cholangitisNov. 20 2024
Source Page: Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsNov. 20 2024
Source Page: Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis